Drug Topics

JUNE 30, 2025

In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.

Compounding 504

Compounding Specialty Pharmacies Independent Pharmacies Patient Care 504

Drug Topics

JULY 25, 2025

The 2024 National Pharmacist Workforce Study reveals a profession under pressure. READ MORE: Why More Pharmacists Are Exploring Nontraditional Roles Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Final Report of The 2024 National Pharmacist Workforce Survey.

Specialty Pharmacies 190

Specialty Pharmacies Independent Pharmacies Patient Care Compounding 190

Drug Topics

JUNE 19, 2025

FDA Grants Interchangeability Designation to Adalimumab-Bwwd for Humira Ashley Gallagher May 28th 2025 Article This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.

FDA 343

FDA Specialty Pharmacies Compounding Independent Pharmacies 343

Drug Topics

JUNE 9, 2025

2024 Dec 10;84(24):2393-2403. Epub 2024 Aug 31. 2024 Oct 19;404(10462):1536-1546. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension. J Am Coll Cardiol. doi: 10.1016/j.jacc.2024.08.025. 2024.08.025. PMID: 39217570. doi: 10.1016/S0140-6736(24)01744-6.

FDA 282

FDA Specialty Pharmacies Compounding Independent Pharmacies 282

Drug Topics

JUNE 18, 2025

March 21, 2024. KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs. May 10, 2024. link] Recent Videos Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5 As obesity rates rise in the U.S.

Compounding 343

Compounding Specialty Pharmacies Independent Pharmacies Immunization 343

Drug Topics

JULY 22, 2025

2 Glucagon-like peptide-1 (GLP-1) receptor agonists keep growing in popularity, and at the American Diabetes Association’s 85th Scientific Sessions, investigators showed the increase in pediatric patients with type 2 diabetes from 2019 to 2024. in 2024, according to the results. in 2019 to 60.9% Approximately 53.9% Approximately 20.3%

Specialty Pharmacies 343

Specialty Pharmacies Compounding Hospitals Independent Pharmacies 343

Drug Topics

JULY 10, 2025

PwC’s 2024 Voice of the Customer report found that 80% of consumers are willing to pay more for sustainably produced or sourced goods, despite overall rising costs. sustainability premium, even as cost-of-living and inflationary concerns weigh: PwC 2024 Voice of the Consumer Survey. Newsletter Pharmacy practice is always changing.

Health and Personal Care Stores 247

Health and Personal Care Stores Independent Pharmacies Labelling Specialty Pharmacies 247

Drug Topics

JUNE 11, 2025

From 1980 to 2024, the National Centers for Environmental Information reported 403 confirmed natural disaster events impacting weather or climate, totaling economic losses over $1 billion. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.

Health and Personal Care Stores 316

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Communication 316

Drug Topics

JUNE 20, 2025

Pneumococcal Burden Remains Despite Immunization Expansion Ashley Gallagher June 9th 2025 Article The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.

Vaccines 316

Vaccines Immunization Specialty Pharmacies Compounding 316

Drug Topics

JULY 2, 2025

2024 Nov 15:dgae778. Tillman JB, Beck RW, Polonsky WH, et al. Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A Six-Month Analysis. J Clin Endocrinol Metab. doi: 10.1210/clinem/dgae778. Epub ahead of print. PMID: 39546625.

Patient Care 316

Patient Care Specialty Pharmacies Compounding Independent Pharmacies 316

Drug Topics

JULY 14, 2025

Dynamics that have become apparent during 2024 have driven significant revisions to the outlook, and in this report, the drivers of change in medicine spending over the next 5 years are deconstructed to enable better understanding,” wrote IQVIA. There [were] up to 48 novel drugs launched in the US in 2024; 31 of them were orphan drugs.

Immunization 247

Immunization Compounding Specialty Pharmacies Independent Pharmacies 247

Drug Topics

JULY 2, 2025

April 4, 2024. Innovators who fought to unlock GLP-1 drugs for obesity awarded Mani L. Bhaumik Breakthrough of the Year Award. American Association for the Advancement of Science. Accessed July 1, 2025. Comparing Ozempic, Wegovy and other GLP-1 drugs. February 14, 2025. Accessed July 2, 2025.

Compounding 450

Compounding Patient Care Specialty Pharmacies FDA 450

Drug Topics

JUNE 18, 2025

Published 2024 Nov 25. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. Eggers S, Hoggarth ZE, Nagdeo K, et al. Food Insecurity Modifies the Association Between the Gut Microbiome and the Risk of Cognitive Impairment in Adults. rs-5486286. doi:10.21203/rs.3.rs-5486286/v1 rs-5486286/v1 3. Drug Topics.

Communication 378

Communication Specialty Pharmacies Compounding Independent Pharmacies 378

Drug Topics

JUNE 6, 2025

December 18, 2024. Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: [link] 4. Mayo Clinic. Inflammatory bowel disease (IBD). Accessed June 6, 2025. Crohn’s and Colitis Foundation. IBD Pharmacists. Accessed June 6, 2025.

FDA 282

FDA Immunization Mayo Clinic Specialty Pharmacies 282

PQA

APRIL 25, 2025

During pharmacy school, Melody made a lasting impact through leadership, mentorship, and community service. As the 2024-2025 Student National Pharmaceutical Association (SNPhA) Region III Facilitator, she oversaw 25 pharmacy school chapters, launching initiatives to promote collaboration and professional development.

Specialty Pharmacies 52

Specialty Pharmacies Patient Care Hospitals 52

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.

Vaccines 73

Vaccines Compounding Pharmacies Immunization Hospitals 73

Drug Topics

JULY 18, 2025

April 12, 2024. link] Newsletter Pharmacy practice is always changing. Shingrix approved in the US for prevention of shingles in immunocompromised adults. News Release. July 26, 2021. Accessed July 18, 2025. Shingles Facts and Stats. Accessed July 18, 2025.

Vaccines 343

Vaccines FDA Specialty Pharmacies Independent Pharmacies 343

Pharmacy Times

JULY 22, 2025

FluMist (live intranasal influenza vaccine; AstraZeneca) was approved in September 2024 for self- and caregiver administration for individuals aged 2 to 49 years. 8 This percentage is lower than the previous season (53%), which contributed to 250 pediatric deaths during the 2024-2025 influenza season. September 17, 2024.

Vaccines 50

Vaccines Immunization Compounding Pharmacies FDA 50

Pharmacy Times

JULY 25, 2025

Last Updated October 26, 2024. Last Updated October 4, 2024. Pneumococcal disease­­—pneumococcal vaccine recommendations. Accessed July 23, 2025. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Accessed July 23, 2025. Hong K, Zhou F, Tsai Y, et al.

Vaccines 65

Vaccines Compounding Pharmacies Immunization Compounding 65

Pharmacy Times

JULY 16, 2025

14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.

HIV Treatment and Prevention Agents 65

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Chemotherapy 65

Drug Topics

JUNE 23, 2025

Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Health and Personal Care Stores 452

Health and Personal Care Stores CPhT Immunization Vaccines 452

Drug Topics

JULY 17, 2025

November 8, 2024. August 30, 2024. link] Newsletter Pharmacy practice is always changing. The impact of pharmacist-led interventions on the treatment of COPD patients. Med Princ Pract. 2025; [link] 2. What is COPD? National Heart, Lung, and Blood Institute. Accessed July 17, 2025. Mayo Clinic Staff. Mayo Clinic.

Specialty Pharmacies 247

Specialty Pharmacies Mayo Clinic Patient Care Compounding 247

Drug Topics

JUNE 19, 2025

Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

CPhT 316

CPhT Independent Pharmacies Immunization Vaccines 316

Pharmacy Times

JUNE 27, 2025

5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.

FDA 56

FDA Compounding Pharmacies Immunization Chemotherapy 56

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. 2 From October 2024 to March 2025, the CDC reported at least 37 million influenza infections, 480,000 hospitalizations, and 21,000 deaths.

Vaccines 117

Vaccines Immunization Hospitals Compounding Pharmacies 117

Pharmaceutical Commerce

JUNE 18, 2025

9, 2024—seven weeks before the one-year stabilization period was set to end. Stakeholders are aware that this federal law—enforced by the FDA and originally enacted in 2013 as a way to help bolster security and traceability of products passing through the pharma supply chain—has seen its share of delays and exemptions over the years.

Specialty Pharmacies 52

Specialty Pharmacies Documentation FDA 52

Drug Topics

JUNE 17, 2025

Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Community Pharmacies 217

Community Pharmacies CPhT Immunization Vaccines 217

Pharmacy Times

JULY 23, 2025

As this market surges toward unprecedented growth over the next decade, specialty pharmacies are increasingly turning to automation to meet demand and manage costs. Specialty pharmacies that prioritize efficiency over empathy risk missing what matters most: Meaningful connection during a critical moment in care.

Specialty Pharmacies 50

Specialty Pharmacies Compounding Pharmacies Immunization Compounding 50

Pharmacy Times

JUNE 4, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies Compounding Immunization Specialty Pharmacies 65

Pharmacy Times

JUNE 24, 2025

Updated April 2, 2024. A study of JNJ-68284528, a chimeric antigen receptor T cell (CAR-T) therapy directed against B-cell maturation antigen (BCMA) in participants with relapsed or refractory multiple myeloma (CARTITUDE-1). Accessed June 24, 2025.

Compounding Pharmacies 123

Compounding Pharmacies Immunization Hospitals Compounding 123

Pharmaceutical Commerce

JUNE 18, 2025

Asembia’s AXS25 Summit—held annually at both the Wynn and Encore in Las Vegas, NV—brings together thousands of pharmaceutical industry executives in hopes of continuing the conversation surrounding specialty pharmacy.

Specialty Pharmacies 52

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

JUNE 16, 2025

The FDA approved nemolizumab in December 2024 for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not controlled by topical prescription therapies among individuals 12 and older. May 15, 2024. Pharmacy Times. December 16, 2024.

Compounding Pharmacies 65

Compounding Pharmacies FDA Immunization Mayo Clinic 65

Pharmacy Times

JULY 21, 2025

Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L.

Compounding Pharmacies 65

Compounding Pharmacies Immunization Insurance Coverage Hospitals 65

Pharmacy Times

JUNE 9, 2025

Presented at: American Society of Health-System Pharmacists 2025 Pharmacy Futures. 2024 Global Strategy for Asthma Mnagement and Prevention Guidelines. A comprehensive evaluation of asthma therapy within a large healthcare system. Charlotte, NC; June 9, 2025. Global Initiative for Asthma. Accessed June 9, 2025.

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

Pharmacy Times

JULY 18, 2025

Updated November 14, 2024. Updated October 31, 2024. Lastly, pharmacists should consider offering mail-back envelopes at no charge to provide patients with a convenient and secure alternative to other disposal options. REFERENCES 1. The impact of pharmaceuticals released to the environment. Accessed June 6, 2025. 2020;6(7):e04551.

HIV Treatment and Prevention Agents 50

HIV Treatment and Prevention Agents Compounding Compounding Pharmacies Immunization 50

Pharmacy Times

JULY 12, 2025

Since launching the service in September 2024, they’ve dispensed more than 300 boxes, with an estimated 72% acceptance rate. 1 This service can not only expand pharmacies’ clinical offerings but serves a crucial public health benefit.

Independent Pharmacies 65

Independent Pharmacies Hospitals Compounding Pharmacies Immunization 65

Pharmacy Times

JUNE 12, 2025

Prior to the start of OPC on June 19, participants are invited to attend the Hematology/Oncology Pharmacy Association (HOPA) BCOP Program in person on June 18. HOPA has selected 4.0 Additional information is available here.

Compounding Pharmacies 113

Compounding Pharmacies Vaccines Immunization Specialty Pharmacies 113